PFIZER AGREEMENT ESTABLISHES MOST-FAVORED-NATION PRICING UNDER EXECUTIVE ORDER 14297
WHAT DOES THE PFIZER MOST-FAVORED-NATION AGREEMENT MEAN FOR U.S. TRADE POLICY? On September 30, 2025, the White House announced an agreement with Pfizer establishing the first application of most-favored-nation (MFN) pricing to U.S. pharmaceuticals. The policy is based on Executive Order 14297, signed May 12, 2025, “Delivering Most-Favored-Nation Prescription Drug [...]
